首页> 外国专利> Improved bioavailability of itraconazole for oral administration

Improved bioavailability of itraconazole for oral administration

机译:伊曲康唑口服的生物利用度提高

摘要

The present invention, by shaping non-a, more particularly the determination of the itraconazole original formulation used for the antifungal agent at the same time as solid dispersion Sikkim the polyvinylpyrrolidone and the absorption enhancer said agent relates to itraconazole formulations for oral enhanced the bioavailability , polyvinylpyrrolidone is itraconazole the inclusion of money and the absorption enhancing agents to increase the solubility of the effective blood concentration of the body fluids in the digest gastrointestinal tract by taking a dose with less number of times of less drug than conventional sikimyeo significantly increase the bioavailability the depending reduce the burden on the usage and gastrointestinal discomfort due to excessive administration of drugs and, during storage relates to a formulation for itraconazole not amorphous itraconazole is not converted to a crystalline form of itraconazole that promote long-term storage stability dramatically orally.
机译:本发明通过将非-a定型,更特别地是确定用于抗真菌剂的伊曲康唑原始制剂与固体分散体锡金,聚乙烯吡咯烷酮和吸收促进剂的同时,所述试剂涉及用于口服的伊曲康唑制剂,其增强了生物利用度,聚乙烯吡咯烷酮是伊曲康唑,包括金钱和吸收增强剂,可通过服用比常规肌醇过少的药物少几次的剂量来增加消化道中体液有效血液浓度的溶解度,从而显着提高生物利用度。取决于减轻药物过量给药的使用和胃肠道不适的负担,并且在贮存期间涉及伊曲康唑的制剂,非结晶伊曲康唑不会转化为伊曲康唑的结晶形式,其可显着提高口服的长期贮存稳定性。

著录项

  • 公开/公告号KR20010098419A

    专利类型

  • 公开/公告日2001-11-08

    原文格式PDF

  • 申请/专利权人 김충섭;

    申请/专利号KR20010014982

  • 发明设计人 이해방;강길선;정제교;조진철;

    申请日2001-03-22

  • 分类号A61K9/10;

  • 国家 KR

  • 入库时间 2022-08-22 01:12:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号